«Williams Syndrome

Below is an extended Williams Syndrome patents listing. Click here to return to the Williams Syndrome main in depth entry.

Patents :
US Patent No.	Title
4877778	Method of enhancing lipophile transport using cyclodextrin derivatives
6708053	Biochemical markers of brain function
6727222	Transcriptional regulator
6787309	Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
6903244	Mice which are +/- or -/- for the elastin gene as models for vascular disease
6919431	Polypeptide-human SNARE protein 25 and a polynucleotide encoding the same
6921654	Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
6936450	Variants of protein kinases
6951924	Antibodies against secreted protein HTEBYII
6977162	Rapid analysis of variations in a genome
7001768	Targeted modification of chromatin structure
6596482	Nucleic acids encoding BAZ1.alpha. transcriptional regulator and methods of use
6385611	System and method for database retrieval, indexing and statistical analysis
6342357	Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
5599673	Long QT syndrome genes
5650282	Diagnosis of Williams syndrome
5840489	Diagnosis and treatment of supravalvular aortic stenosis and Williams syndrome
5858662	Diagnosis of Williams syndrome and Williams syndrome cognitive profile by analysis of the presence or absence of a LIM-kinase gene
5958731	Cell junction PDZ protein
5994098	Human 7-TM receptor similar to murine frizzled-6 gene
6207383	Mutations in and genomic structure of HERG--a long QT syndrome gene
6235879	Apoptosis modulators that interact with the Huntington's disease gene
6251601	Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
6265547	Cell junction PDZ protein
7014997	Chromosome structural abnormality localization with single copy probes
7026447	53 human secreted proteins
7297489	Mutations in and genomic structure of HERG--a long QT syndrome gene
7301067	Mice which are +/- or -/- for the elastin gene as models for vascular disease
7332277	Methods for detection of genetic disorders
7335470	Compilations of nucleic acids and arrays and methods of using them
7335735	Intracellular estradiol binding protein
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7411051	Antibodies to HDPPA04 polypeptide
7420044	Nucleic acid and protein homologs and uses thereof
7294652	Autoimmune conditions and NADPH oxidase defects
7256002	Screening for neurotoxic amino acid associated with neurological disorders
7250496	Bioinformatically detectable group of novel regulatory genes and uses thereof
7035739	Computer systems and methods for identifying genes and determining pathways associated with traits
7053264	Nuclear reprogramming using IWSI and related chromatin remodeling ATPases
7091315	Protein HDPBQ71
7125837	Elastin-based compositions
7163797	50 human secreted proteins
7189818	Transcriptional regulator
7196164	Secreted protein HHTLF25
7202329	Tsg101-GAGp6 interaction and use thereof
7208274	Rapid analysis of variations in a genome
7229788	Protease susceptibility II
7425700	Systems and methods for discovery and analysis of markers

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.